Chart via Yaacov Apelbaum In January of this year, weeks after the coronavirus was first reported in China, the Wuhan Institute of Virology applied for a patent on a US drug, Remdesivir, used to treat coronavirus infections. For starters, Jiang is the grandfather of Jiang Zhicheng, who has a controlling interest in WuXi AppTec, which controls Fosun Pharma. In January of this year, a few months ago as the coronavirus was first being reported in China, the Wuhan Institute of Virology applied for a patent on a US drug, Remdesivir, used for the treatment of Ebola and coronavirus infections. Pentru început, Jiang este bunicul lui Jiang Zhicheng, care incearca sa preia WuXi AppTec, care controlează Fosun Pharma. Washington Clings to the Idea the Novel Coronavirus Came From Nature. In January of this year, a few months ago as the coronavirus was first being reported in China, the Wuhan Institute of Virology applied for a patent on a US drug, Remdesivir, used for the treatment of Ebola and coronavirus infections. In January of this year, weeks after the coronavirus was first reported in China, the Wuhan Institute of Virology applied for a patent on a US drug, Remdesivir, used to treat coronavirus infections. For starters, Jiang is the grandfather of Jiang Zhicheng, Who has a controlling interest in WuXi AppTec, which controls Fosun Pharma. For starters, Jiang is the grandfather of Jiang Zhicheng, Who has a controlling interest in WuXi AppTec, which controls Fosun Pharma. The State Department, NIH and CDC know far more than they are telling . For starters, Jiang is the grandfather of Jiang Zhicheng, who has a controlling interest in WuXi AppTec, which controls Fosun Pharma. For starters, Jiang is the grandfather of Jiang Zhicheng, who has a controlling interest in WuXi AppTec, which controls Fosun Pharma. For starters, Jiang is the grandfather of Jiang Zhicheng, Who has a controlling interest in WuXi AppTec, which controls Fosun Pharma.

George Soros deține și Gilead Biosciences. Stephen Bryen. In January of this year, a few months ago as the coronavirus was first being reported in China, the Wuhan Institute of Virology applied for a patent on a US drug, Remdesivir, used for the treatment of Ebola and coronavirus infections. Chart via Yaacov Apelbaum: In January of this year, weeks after the coronavirus was first reported in China, the Wuhan Institute of Virology applied for a patent on a US drug, Remdesivir, used to treat coronavirus infections. Dar această poveste nu se termină aici.